This symposium aims to provide an update on all aspects of Kidney transplantation carried out by expert clinicians in the field. Further this will allow the participants to get exposed to learn about difficult cases handled throughout the year, whilst having the opportunity take part in the panel discussions with the expert clinicians from the field.
Register your place at the symposium on our eStore page.
Find out more about the symposium on our programme.
At the end of this symposium, the participants will:
- Get an update in all aspects of kidney transplantation
- Learn about evidence-based kidney transplantation activities carried out by experts
- Learn about focus on the current practice, changes and future directions of Kidney transplantation
Upon completion, the participants will have an update on all aspects of renal transplantation.
About Guy's Hospital
Guy’s Hospital is a leading institution in the field of renal transplantation. We celebrated our 50th anniversary since the first kidney transplantation in the year 2022.
The Department of Renal and Transplant at Guy’s is one of the largest in the UK, providing kidney care to South East London, neighboring areas of Kent and the Channel Islands. In addition, we receive a significant number of complex referrals from a much wider geographical area.
We perform over 280 transplants each year, have the largest living kidney donor programme in the country and are a supra-regional centre for both combined kidney/pancreas and pancreas alone transplantation. We have one of the largest blood group and HLA incompatible transplant programmes in the UK.
We have expertise in transplant urology, dual kidney transplantation and in complex transplant recipients including recipients with sickle cell disease and antiphospholipid syndrome.
We are nationally recognised for quality of care, innovation in clinical practice and service delivery, and for our close functional and geographical integration with the research programmes of partners at Kings College London and the Comprehensive Biomedical Research Centre.
If you have any questions, please contact email@example.com.
'Guy's Hospital Kidney Transplantation Course' is subject to be approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 12 category 1 (external) CPD credit(s).
The Royal College of Physicians (RCP) provides accreditation as a supportive process of evaluating the quality of clinical services and promotes quality improvement through highlighting areas of best practice and areas for change, encouraging the continued development of the clinical service.
This course has also received endorsements from the following organisations.
The European Kidney Transplant Association (EKITA)
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients.
More information about the EKITA can be found on their website.
The UK Kidney Association
The UK Kidney Association is a professional body for the UK kidney community that represents people working in clinical renal care, treating and caring for people with kidney disease, those working in research, or related sciences and fields and all allied healthcare professionals as members.
More information about the UK Kidney Association can be found on their website.
The King’s Centre for Nephrology, Urology and Transplantation would like to appreciate our partners ‘King’s College Hospital Charity’ and ‘Guy’s & St Thomas Charity’ for supporting us to create a self-sustaining educational arm for Nephrology, Urology & Transplantation education.
King's College Hospital Charity
We are dedicated to supporting life-changing care for patients at King’s College Hospital NHS Foundation Trust (King’s). We have a small but dedicated team of fundraisers, finance and administrative staff based near King's Denmark Hill campus. The Charity is led by Chief Executive, Gail Scott-Spicer, and governed by a Board of Trustees.
Donate to King's College Hospital Charity.
Guy’s and St Thomas’ Charity
We are the charity that is proud of hundreds of years of looking forward. Of backing dedicated teams across Guy’s and St Thomas’ NHS Foundation Trust whose commitment to change and challenge is part of their DNA. Caring for patients and families is at the heart of everything they do. And so we’re helping them go that bit further, beyond what the NHS can provide.
Donate to Guy's & St Thomas' Charity.
This course has been supported by pharmaceutical companies including Chiesi, Sandoz, CSL Vifor, Pharmacosmos, Stanningley Pharma, AstraZeneca and Xvivo through the purchase of exhibition space and have not contributed to the organisation or content of this course.
We would like to extend our appreciation to all our sponsors who have provided sponsorship to the Guy’s Hospital Kidney Transplantation Course 2023.
As a B Corp in the biopharmaceutical industry, Chiesi is counted among businesses that are leading a global movement for an inclusive, equitable, and regenerative economy. It is an achievement to be proud of, and yet one that feels natural: caring for others lies at the root of health science and has always been at the heart of our work.
More information about Chiesi can be found on their website.
Sandoz is a global leader in generic pharmaceuticals and biosimilars and a division of the Novartis Group. Sandoz contributes to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine.
More information about Sandoz can be found on their website.
At Pharmacosmos, we are specialists in iron therapy. We develop, manufacture and market medicines for the treatment of iron deficiency anaemia in humans and animals. We are furthermore specialists in developing and producing advanced carbohydrates for pharmaceutical and technical uses.
More information about Pharmacosmos can be found on their website.
Stanningley Pharma is a privately owned British healthcare company committed to developing products which improve the quality of life for patients in the context of a modernising NHS. The company’s primary interest is the provision of products for people with chronic kidney failure, but it also provides products in other specialist therapeutic areas within hospital medicine.
More information about Stanningley Pharma can be found on their website.
AstraZeneca is a global pharmaceutical company with a major UK presence. Our purpose is to push the boundaries of science to deliver life-changing medicines. The best way we can help patients is to be science-led and share this passion with the scientific, healthcare and business communities of the UK.
More information about AstraZeneca can be found on their website.
The first global all organ company. Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs – so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine.
More information about XVIVO can be found on their website.
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan.
More information about Takeda can be found on their website.